Sample size is too low but very encouraging.
The 83% headline is a bit misleading but only a tiny bit. If we do like for like comparison of 'completed' outcomes:
78% on sample size 9 is still amazing though but even thinner for my liking.
Surer numbers will come out after the full 240 patient trial comes out (Announced 9th April)
From a purely stat point of view, seeing how likely these kind of results are, we have to consider the whole population, including those who are still hospitalized.
Using the same data, the results are a bit less impressive.
IHD%R ² î R5õ IDATxÜÝÙ³fÉqöü¶»ßÞ§gzv@¬A‚@€»C|#
Sample size is too low but very encouraging. The 83% headline is...
-
- There are more pages in this discussion • 367 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |